Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe phrase "Mounjaro introductory offer" shows up everywhere online, but what it describes — and what it means for you — is worth unpacking carefully. Mounjaro (tirzepatide) is a prescription-only medicine, so the clinical assessment that comes before any prescription is as much a part of the service as the treatment itself. Any legitimate route to Mounjaro starts with a prescriber deciding whether it's appropriate for you, not a promotional price. That said, the question behind the search is fair: people want to know whether starting treatment is financially sensible, and what the real first-month picture looks like. This page explains what to expect, what to watch for, and how to make that decision on solid ground.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A starter dose of 2.5 mg exists in the Mounjaro schedule for a specific reason: your body needs time to adjust to tirzepatide before the dose climbs. That first month is not a trial run or a promotional tier. It's a calibration phase. Most people experience the heaviest gastrointestinal side effects (nausea, loose stools, a general off feeling) during this period, and the 2.5 mg dose is set at that level precisely to keep those effects manageable. The 2.5 mg pen contains four weekly doses, so one pen covers your first month.
Where the word "introductory" causes confusion is when it's attached to pricing. Some providers price the first pen lower to attract sign-ups, then adjust for subsequent doses. Others charge more for higher doses as you titrate upward, which means the first-month cost may look appealing but the ongoing cost less so. Neither approach is inherently wrong, but it means any single headline price tells you only part of the story. The realistic monthly cost of Mounjaro treatment includes the medicine, clinical oversight, the prescription, and delivery, not just the pen itself.
The NHS describes tirzepatide on its medicines pages and NICE's appraisal of tirzepatide (TA1026) sets out the clinical evidence base, both are worth reading if you want to understand what the treatment is before deciding whether to start it.
People searching for an introductory offer are usually asking one of two things: is it worth trying, and can I afford to give it a proper go? Those are sensible questions. The answer to the first sits in your consultation, a prescriber reviews your health history, current medications, BMI, and any relevant conditions before deciding whether Mounjaro is appropriate for you. No offer changes that step. It can't be skipped, and with a GPhC-registered pharmacy it won't be.
The second question is more practical. Committing to a medicine that requires consistent use over months is a financial decision as much as a health one. It's worth thinking about your order timing before you start, if payday falls mid-month, for instance, setting up your repeat orders to align with it makes the process less stressful. If you're wondering whether a current Mounjaro offer applies to your situation, what a legitimate service should give you from day one is total cost transparency: what you pay, what that covers, and no automatic renewals.
At nume, every prescription is reviewed by a GPhC-registered Independent Prescriber before it's issued. There are no subscriptions. Each repeat order is individually approved. You can verify our pharmacy on the GPhC register using premises registration number 9012878.
Mounjaro is a Prescription-Only Medicine. Under the Human Medicines Regulations 2012, advertising POMs to the public is tightly restricted, and the MHRA has stated clearly that GLP-1 medicines are not assessed for quick or cosmetic weight loss. That regulatory context matters for "offers". A legitimate pharmacy cannot run discount codes on prescription medicines, the pricing exists within a clinical and legal framework that doesn't accommodate promotional discounting.
When you see a code or a voucher being promoted for Mounjaro by an online seller, it is either a compliant service describing a genuine price (in which case there's no code involved, just a stated price), or it is a signal worth taking seriously. The MHRA has seized large quantities of counterfeit weight-loss pens over the past two years, some fake pens have contained insulin rather than tirzepatide, with serious consequences for people who used them. The guide to Mounjaro offer codes covers this in more detail if you're trying to make sense of what you've seen.
You can report any suspect seller directly via the MHRA's Yellow Card scheme. And you can check whether any online pharmacy is legitimately registered at the GPhC register before handing over personal or medical information.
If you're approved following your consultation, the 2.5 mg pen is your starting point. It covers four weekly injections. You're not titrating yet, your prescriber will assess how you've responded before any dose change. Common effects in this period are digestive: nausea tends to peak in the first couple of weeks and ease as your system adapts. Staying hydrated, eating smaller meals, and avoiding fatty or very rich food during this phase helps most people through it, as the NHS tirzepatide medicines page notes.
The pen itself is pre-filled and pre-set, there's no measuring or drawing up of doses. Injection sites are the abdomen, thigh, or upper arm, rotated weekly. Storage is in the fridge. If you want a broader picture of what Mounjaro treatment involves before your consultation, the Mounjaro overview and the tirzepatide explainer are good starting points, and you can also read about how Mounjaro is assessed for suitability if you'd like to understand the clinical criteria in more detail.
Once you've completed your first month, your prescriber reviews how things are going. That review shapes the next step, whether that's continuing at 2.5 mg a little longer, moving to 5 mg, or something else. It's a conversation, not a conveyor belt. If you'd like to explore whether treatment is right for you, check your eligibility with a free consultation and a prescriber will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.